In B cells, FcRL3 expression can amplify signalling through Toll-like receptors, particularly TLR9, thereby promoting activation of autoreactive cells and increasing the production of autoantibodies such as ACPAs, characteristic of RA [24,33]. This evidence concerns the gene TLR9 and rheumatoid arthritis.